Torcetrapib-induced blood pressure elevation is independent of cholesteryl ester transfer protein inhibition and is accompanied by an increase in circulating aldosterone levels

被引：0
|
作者：
Forrest, Michael J.
Bloomfield, Daniel
Briscoe, Richard J.
Ehrhart, Juliann
Hershey, James C.
Ma, Xiuying
Peterson, Laurence B.
Siegl, Peter K.
Sinclair, Peter J.
Stevenson, Andra S.
Sun, Shu-Yu
Vargas, Hugo M.
Walker, Matthew
Sparrow, Carl P.
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, West Point, PA USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
CIRCULATION RESEARCH | 2007年 / 101卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4020
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 36 条
  • [21] Inhibition of Cholesteryl Ester Transfer Protein Contributes to the Protection of Ginsenoside Re Against Isoproterenol-Induced Cardiac Hypertrophy
    Qiu, Yumei
    Xie, Mengdie
    Ding, Xiaoyun
    Zhang, Hao
    Li, Hongming
    Wang, Hu
    Li, Tingting
    Dong, Wei
    Jiang, Fangqin
    Tang, Xilan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [22] Cholesteryl ester transfer protein: Pharmacological inhibition foe the modulation of plasma cholesterol levels and promising target for the prevention of atherosclerosis.
    Ruggeri, RB
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (03) : 257 - 264
  • [23] Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein
    Liang, Yi-Qiang
    Isono, Masato
    Okamura, Tadashi
    Takeuchi, Fumihiko
    Kato, Norihiro
    [J]. HYPERTENSION RESEARCH, 2020, 43 (07) : 655 - 666
  • [24] Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein
    Yi-Qiang Liang
    Masato Isono
    Tadashi Okamura
    Fumihiko Takeuchi
    Norihiro Kato
    [J]. Hypertension Research, 2020, 43 : 655 - 666
  • [25] Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults
    Suico, Jeffrey G.
    Wang, Ming-Dauh
    Friedrich, Stuart
    Cannady, Ellen A.
    Konkoy, Christopher S.
    Ruotolo, Giacomo
    Krueger, Kathryn A.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2014, 66 (11) : 1576 - 1585
  • [26] Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits
    Shimoji, E
    Zhang, B
    Fan, P
    Saku, K
    [J]. ATHEROSCLEROSIS, 2004, 172 (02) : 247 - 257
  • [27] DECREASE OF HEPATIC TRIGLYCERIDE LIPASE LEVELS AND INCREASE OF CHOLESTERYL ESTER TRANSFER PROTEIN-LEVELS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - RELATIONSHIP TO ABNORMALITIES IN HIGH-DENSITY-LIPOPROTEIN
    HIRAOKA, H
    YAMASHITA, S
    MATSUZAWA, Y
    KUBO, M
    NOZAKI, S
    SAKAI, N
    HIRANO, K
    KAWATA, S
    TARUI, S
    [J]. HEPATOLOGY, 1993, 18 (01) : 103 - 110
  • [28] Inhibition of cholesteryl ester transfer protein (CETP) activity increases paraoxonase (Pon1) activity toward paraoxon and decreases plasma lysophosphatidylcholine (LysoPC) levels
    Zhang, B
    Fan, P
    Shimoji, E
    Saku, K
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 70 - 70
  • [29] Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels - Pathways by which modulation of CETP activity may alter atherogenesis
    Klerkx, AHEM
    El Harchaoui, K
    van der Steeg, WA
    Boekholdt, SM
    Stroes, ESG
    Kastelein, JJP
    Kuivenhoven, JA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (04) : 706 - 715
  • [30] Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk
    Arsenault, Benoit J.
    Petrides, Francine
    Tabet, Fatiha
    Bao, Weihang
    Hovingh, G. Kees
    Boekholdt, S. Matthijs
    Ramin-Mangata, Stephane
    Meilhac, Olivier
    DeMicco, David
    Rye, Kerry-Anne
    Waters, David D.
    Kastelein, John J. P.
    Barter, Philip
    Lambert, Gilles
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 130 - 136
1234